This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Peptide Therapeutics Market

Market Insights on Peptide Therapeutics covering sales outlook, demand forecast & up-to-date key trends

Peptide Therapeutics Market By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly) & Region for 2022-2025

Peptide Therapeutics Market Outlook (2022-2025)

[220 Pages Report] The global Peptide Therapeutics Market is currently valued at US$ 34.4 Bn, and is expected to reach US$ 47 Bn by 2025, expanding at an impressive CAGR of 11% over the period of 2022 to 2025.

Peptide Therapeutics Market Size (2022)

US$ 34.4 Bn

Revenue Forecast (2025)

US$ 47 Bn

Global Market Growth Rate (2022-2025)

11% CAGR

Dominant Route of Administration

Parenteral Route (70.7%)

Peptide therapeutics currently account for 53.7% share of the global drug discovery market, with the Asia Pacific market advancing rapidly in peptide-based drugs. For more than a century, peptide medicines have been used to treat metabolic illnesses. In comparison to tiny chemical compounds, peptide drugs offer numerous advantages, resulting in huge demand across geographies.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

11.24%

H1, 2022 Projected

10.88%

H1, 2022 Outlook

10.68%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 20 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 56 ↓

The comparative analysis and market growth rate of global peptide therapeutics market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 20 BPS, and, a negative BPS dip is expected in H1-2022 over H1- 2021 duration with 56 Basis Point Share (BPS).

The dip in the BPS values observed is due to the high cost factors associated with manufacturing a peptide, as well as the limitation of the molecule having a short half-life, therefore incurring high research expenditures.  However, with a wide range of targets available for peptides, manufacturers have opportunities to develop novel peptide therapeutic formulations, thus impacting the overall market positively.

The market is subject to changes in lieu of factors such as research funding and grants and outsourcing of manufacturing capabilities, in accordance to the macro and industry standards. Conversely, advancements in next generation therapeutics and peptide based targeted drug delivery for cancer cells will aid in the positive growth traction of the overall market.

Peptide Therapeutics Demand Analysis (2014 To 2021) Vs Market Outlook (2022 To 2025)

The peptide therapeutics market expanded at a CAGR of 10% from 2014 to 2021.

Peptide therapeutic companies have come to appreciate the role that peptide pharmaceuticals can play in addressing unmet medical needs, and how this class of compounds can be an excellent complement or even a preferable alternative to small molecule and biological therapeutics, resulting in a revival of interest and scientific momentum in peptide drug discovery over the last decade.

The market is being driven by rising prevalence of cancer and metabolic disorders, increased investments in research & development of innovative medications, and technological developments in peptide therapies.

Peptide Therapeutics Market Download Report Brochure

Peptide pharmaceuticals have developed a wide range of applications in medicine and biotechnology during the last decade, and therapeutic peptide research is undergoing a revival for commercial reasons. Peptide drug discovery has a significant role in the healthcare sector.

  • LupronTM, a peptide medication from Abbott Laboratories, is used to treat prostate cancer and other conditions.

Chronic diseases such as cancer cardiovascular disease, and diabetes are the major causes of death and disability worldwide, according to the World Health Organization (WHO). As a result, rising prevalence of chronic diseases is driving demand for effective medicines, which is likely to propel the peptide therapeutics market forward.

Peptide therapeutics demand is predicted to surge at a CAGR of 11% from 2022 to 2025, with the global market expected to close in on a valuation of US$ 47 Bn by 2025.

Global Peptide Therapeutics Market: Trends And Opportunities

“Oral Peptide-based Drugs Becoming a Hit”

Due to a decrease in non-peptide chemical medications accessible in the market, sales of peptide therapeutic companies are currently rising. The peptides generics market is expected to develop as the patent cliff rises.

Because pharma businesses are shifting their focus to better potential in the peptide therapies sector, CMOs that provide end-to-end services to biotech pharmaceutical companies are rising.

As peptides are a common component of food, both, the stomach and intestines contain a plethora of enzymes that can break them down, and most peptide-based drugs do not survive the gastrointestinal tract.

  • Heinis's Group is currently using a novel technology to develop oral peptide drugs that act directly on gastrointestinal targets, bypassing the bloodstream. Oral peptide drugs will play a crucial role in the treatment of a wide range of disorders.

“Increasing Use of Peptides in Cancer & Diabetes Treatment”

Peptides were originally used solely for diagnostics and hormone therapy; however, with technological advancements, they are now widely used for the treatment of cancer and chronic metabolic illnesses as well.

Chemotherapy, which is the most common kind of cancer treatment, is beset by problems due to its inability to deliver the right amount of medicine to the right place at the right time. It also affects the body's natural cells. Use of peptide-based therapeutics in cancer treatment has opened up a promising new channel for the peptide therapeutics market's future growth.

Apart from that, peptide therapies are widely utilised in injections for diabetic patients, thanks to the emergence of novel synthetic techniques that reduce injection frequency while also improving stability and other physical features.

This is influencing the usage of peptide therapies over oral drugs, which coincides with the rising incidence of diabetes and growing preference for rapid and accurate treatment techniques.

“Rising Popularity of Peptide-based Therapeutics in Cosmeceuticals”

Peptides are also employed in cosmeceutical operations to slow down the ageing process of the skin. This, combined with people's growing awareness of their physical appearance and a desire to keep their skin looking young and healthy, is fuelling global acceptance of cosmetic operations and peptide-based therapeutics.

Furthermore, the need for multifunctional peptide-based drug materials is being fuelled by the growing trend of tailored and targeted treatments. This, together with increased investments for the development of new peptide therapies for the treatment of autoimmune and inflammatory illnesses, is expected to boost market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Regional Markets Are Set To Be Lucrative For Peptide Therapeutics Drug Manufacturers?

“High Government Investments in R&D of Peptide Medications Fuelling Market Growth in North America”

The global peptide therapeutics market has been studied across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA). 

Throughout the projected period, North America is expected to lead the global market. This regional market is prominent as a result of factors such as increased awareness of peptide treatments, growing need for diagnostics in cancer and other diseases, and the expanding biotechnology industry.

Increased government and industry spending on research and development is also predicted to help peptide therapies maintain their dominance over the coming years. In this region, a well-established biopharmaceutical and pharmaceutical industry is a primary driver for market growth.

The peptide therapeutics markets in Western Europe and Eastern Europe are expected to be driven by rising popularity of peptide therapeutics treatment procedures, increasing medical research & development, etc.

The Latin America peptide therapeutics market is expected to account for steady market growth.

The Asia Pacific peptide therapeutics market is predicted to expand at a high CAGR throughout the forecast period, making it a highly viable market. This is due to a large patient pool, rising healthcare expenditure, and increasing need for innovative and advanced therapies.

The MEA peptide therapeutics market is expected to progress at a slightly slower rate than other regions, but is expected to pick up pace in towards the end of the projection period.

Country-Wise Analysis

What Factors are Fuelling Demand for Peptide Therapeutics in the U.S.?

 “High Incidence of Cancer Driving Demand for Peptide-based Therapeutics”

According to the American Cancer Society's forecasts, a little more than 1.9 Mn new cancer cases are predicted to be diagnosed in the United States in 2022. Cancer is the 2nd leading cause of death in the United States, trailing only heart disease.

This data suggests that peptides will become more relevant in the United States' healthcare industry, and that peptides will progress through clinical trials. Demand for peptide therapies is predicted to rise as cancer becomes more prevalent.

Due to factors such as an increase in the number of research programmes in the medical business as well as an increase in the number of diseases in the country, the United States has the biggest market share.

What is the Outlook for Peptide Therapeutics Market in India?

“Growing Adoption of Synthetic Peptide Drugs in India

The India peptide therapeutics market is predicted to grow at a healthy rate over the coming years. Increased frequency of chronic diseases, increasing ageing population, and rising healthcare costs are all contributing to market expansion in the country.

In terms of the number of cancer cases, India is ranked third among all nations. According to the National Cancer Registry Programme report, over 1,300,000 people in India are diagnosed with cancer each year. This surge is attributed to unhealthy lifestyles, increased urban pollution, cigarette and alcohol consumption, and rise in obesity.

According to the Indian Council of Medical Research (ICMR), cancer cases in India will climb 12% in the next five years. Breast cancer, cervical cancer, and oral cancer are the most common types of cancer among Indians.

Synthetic peptide drugs can be made to look like naturally occurring peptides and can be used to treat cancer and other serious illnesses.

  • Hemmo has been supplying peptide products and custom peptide synthesis for more than 38 years, making it one of India's major makers of synthetic peptide drugs provider.

Leading market players are huge and well-established, with a high level of brand loyalty. Major peptide therapeutics medication manufacturers in India are Emcure Pharmaceutical Pvt. Ltd., Cipla Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., and Biological E Limited (IN).

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Analysis

Which Route of Administration is Set to Gain High Preference?

“Parenteral Route Highly Preferred for Peptide Drug Delivery”

The parenteral route provides improved bioavailability, faster onset of action, and superior clinical results, making it the preferred option for peptide therapeutic drug delivery. Highest market share of 70.7% is accounted for by the parenteral route of administration of peptide medicines.

Currently, majority of peptide medications are delivered via the parenteral route. Alternative administration modes, including as oral, intranasal, and transdermal delivery routes, are gaining momentum as technology advances.

The parenteral method, on the other hand, has the potential for side effects and necessitates the use of specialized personnel for delivery. As a result, market participants are turning to alternative administration methods, such as the oral route, which causes less pain and eliminates the need for outside assistance.

Adoption of various delivery forms could also allow peptide medicines to be used more widely in other disease areas, such as inflammation, where topical peptide administration could be the foundation for extremely effective new treatments.

Competitive Landscape

The market for peptide therapies is moderately competitive, with numerous significant competitors such as Eli Lilly and Company, AstraZeneca plc, Merck & Co., Inc., Ipsen S.A, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., etc.

Leading peptide therapeutics providers are focusing on market expansion through distribution agreements, collaborative ventures, and white space exploration.

Furthermore, established companies are working with local players in order to strengthen their regional presence and increase their production capacities.

Peptide Therapeutics Industry Report Scope

Attribute

Details

Forecast Period

2022-2025

Historical Data Available for

2014-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • and GCC Countries

Key Market Segments Covered

  • Application
  • Route of Administration
  • Drug Type
  • Region

Key Companies Profiled

Pricing

Available upon Request

Key Segments Of Peptide Therapeutics Market Industry Survey

By Application :

  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Metabolic Disorders
  • Infections
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Dermatology
  • Respiratory Disorders
  • Acromegaly
  • Other Applications

By Route of Administration :

  • Parenteral Route of Administration
  • Mucosal Route of Administration
  • Oral Route of Administration
  • Transdermal of Route Administration

By Drug Type :

  • Branded Drugs
  • Generic/Biosimilar Drugs

By Region :

  • North America Peptide Therapeutics Market
  • Latin America Peptide Therapeutics Market
  • Europe Peptide Therapeutics Market
  • East Asia Peptide Therapeutics Market
  • South Asia & Pacific Peptide Therapeutics Market
  • Middle East & Africa (MEA) Peptide Therapeutics Market

Frequently Asked Questions

The global peptide therapeutics market is estimated to surge at a CAGR of 11% through 2025.

The global peptide therapeutics market is currently valued at approximately US$ 34.4 Bn.

Key peptide therapeutics providers include Eli Lilly and Company, AstraZeneca PLC, Merck & Co., Inc., Ipsen S.A, Novo Nordisk A/S, and Teva Pharmaceutical Industries Ltd.

Demand for peptide therapeutics is anticipated to close in on a valuation of US$ 47 Bn by 2025.

Parenteral route of administration is the most preferred for peptide therapeutics medicines.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Technology Roadmap

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

    4.2. Forecast Factors - Relevance & Impact

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Market Context

    5.1. Product USPs/ Features

    5.2. Product Adoption / Usage Analysis

    5.3. Regulatory Scenario

    5.4. Supply-Chain Analysis

    5.5. Value Chain Analysis

6. Global Market Value (US$ Mn) Analysis 2014-2021 and Forecast, 2022-2025

    6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2025

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Opportunity Analysis, 2022-2025

7. Global Market Analysis 2014-2021 and Forecast 2022-2025, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Application, 2014-2021

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2025

        7.3.1. Cancer

        7.3.2. Cardiovascular

        7.3.3. Central Nervous Systems

        7.3.4. Metabolic Disorders

        7.3.5. Infection

        7.3.6. Hematological Disorders

        7.3.7. Gastrointestinal Disorders

        7.3.8. Dermatology

        7.3.9. Respiratory Disorders

        7.3.10. Acromegaly

        7.3.11. Other Applications

    7.4. Market Attractiveness Analysis By Application

8. Global Market Analysis 2014-2021 and Forecast 2022-2025, By Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022-2025

        8.3.1. Parenteral Route

        8.3.2. Mucosal Route

        8.3.3. Oral Route

        8.3.4. Transdermal Route

    8.4. Market Attractiveness Analysis By Route of Administration

9. Global Market Analysis 2014-2021 and Forecast 2022-2025, by Marketing

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Marketing, 2014-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Marketing, 2022-2025

        9.3.1. Branded

        9.3.2. Generic

    9.4. Market Attractiveness Analysis By Marketing

10. Global Market Analysis 2014-2021 and Forecast 2022-2025, by Region

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2025

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Western Europe

        10.3.4. APEJ

        10.3.5. Eastern Europe

        10.3.6. Japan

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2014-2021 and Forecast 2022-2025

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Application

        11.3.3. By Route of Administration

        11.3.4. By Marketing

    11.4. Market Attractiveness Analysis

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2014-2021 and Forecast 2022-2025

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Application

        12.3.3. By Route of Administration

        12.3.4. By Marketing

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Western Europe Market Analysis 2014-2021 and Forecast 2022-2025

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        13.3.1. By Country

            13.3.1.1. Germany

            13.3.1.2. U.K.

            13.3.1.3. France

            13.3.1.4. Spain

            13.3.1.5. Italy

            13.3.1.6. Nordic countries

            13.3.1.7. BENELUX

            13.3.1.8. Rest Of Western Europe e

        13.3.2. By Application

        13.3.3. By Route of Administration

        13.3.4. By Marketing

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Eastern Europe Market Analysis 2014-2021 and Forecast 2022-2025

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        14.3.1. By Country

            14.3.1.1. Poland

            14.3.1.2. Russia

            14.3.1.3. Rest Of Eastern Europe

        14.3.2. By Application

        14.3.3. By Route of Administration

        14.3.4. By Marketing

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. APEJ Market Analysis 2014-2021 and Forecast 2022-2025

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. India

            15.3.1.3. ASEAN

            15.3.1.4. Australia & New Zealand

        15.3.2. By Application

        15.3.3. By Route of Administration

        15.3.4. By Marketing

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Japan Market Analysis 2014-2021 and Forecast 2022-2025

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        16.3.1. By Application

        16.3.2. By Route of Administration

        16.3.3. By Marketing

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2014-2021 and Forecast 2022-2025

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2025

        17.3.1. By Country

            17.3.1.1. GCC countries

            17.3.1.2. South Africa

            17.3.1.3. Israel

            17.3.1.4. Rest Of MEA

        17.3.2. By Application

        17.3.3. By Route of Administration

        17.3.4. By Marketing

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Competition Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Competition Deep Dive (Tentative List)

        18.3.1. AstraZeneca plc

            18.3.1.1. Overview

            18.3.1.2. Product Portfolio

            18.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.1.4. Sales Footprint

            18.3.1.5. Strategy Overview

                18.3.1.5.1. Marketing Strategy

                18.3.1.5.2. Product Strategy

                18.3.1.5.3. Channel Strategy

        18.3.2. Bachem Holding AG

            18.3.2.1. Overview

            18.3.2.2. Product Portfolio

            18.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.2.4. Sales Footprint

            18.3.2.5. Strategy Overview

                18.3.2.5.1. Marketing Strategy

                18.3.2.5.2. Product Strategy

                18.3.2.5.3. Channel Strategy

        18.3.3. CordenPharma International

            18.3.3.1. Overview

            18.3.3.2. Product Portfolio

            18.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.3.4. Sales Footprint

            18.3.3.5. Strategy Overview

                18.3.3.5.1. Marketing Strategy

                18.3.3.5.2. Product Strategy

                18.3.3.5.3. Channel Strategy

        18.3.4. Eli Lilly and Company

            18.3.4.1. Overview

            18.3.4.2. Product Portfolio

            18.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.4.4. Sales Footprint

            18.3.4.5. Strategy Overview

                18.3.4.5.1. Marketing Strategy

                18.3.4.5.2. Product Strategy

                18.3.4.5.3. Channel Strategy

        18.3.5. Ipsen S.A

            18.3.5.1. Overview

            18.3.5.2. Product Portfolio

            18.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.5.4. Sales Footprint

            18.3.5.5. Strategy Overview

                18.3.5.5.1. Marketing Strategy

                18.3.5.5.2. Product Strategy

                18.3.5.5.3. Channel Strategy

        18.3.6. Merck & Co., Inc

            18.3.6.1. Overview

            18.3.6.2. Product Portfolio

            18.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.6.4. Sales Footprint

            18.3.6.5. Strategy Overview

                18.3.6.5.1. Marketing Strategy

                18.3.6.5.2. Product Strategy

                18.3.6.5.3. Channel Strategy

        18.3.7. Novo Nordisk A/S

            18.3.7.1. Overview

            18.3.7.2. Product Portfolio

            18.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.7.4. Sales Footprint

            18.3.7.5. Strategy Overview

                18.3.7.5.1. Marketing Strategy

                18.3.7.5.2. Product Strategy

                18.3.7.5.3. Channel Strategy

        18.3.8. PolyPeptide Group

            18.3.8.1. Overview

            18.3.8.2. Product Portfolio

            18.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            18.3.8.4. Sales Footprint

            18.3.8.5. Strategy Overview

                18.3.8.5.1. Marketing Strategy

                18.3.8.5.2. Product Strategy

                18.3.8.5.3. Channel Strategy

19. Assumptions and Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 02: Global Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 03: Global Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 04: Global Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Region

Table 05: North America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 06: North America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 07: North America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 08: North America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 09: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 10: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 11: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 12: Latin America Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 13: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 14: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 15: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 16: Western Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 17: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 18: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 19: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 20: Eastern Europe Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 21: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 22: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 23: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 24: APEJ Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 25: MEA Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Country

Table 26: MEA Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 27: MEA Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 28: MEA Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing 

Table 29: Japan Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Application

Table 30: Japan Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Route Of Administration

Table 31: Japan Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2025, By Marketing

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Historical Market Size and Y-o-Y, 2014-2021

Figure 02: Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2025

Figure 03: Global Market Absolute $ Opportunity, 2014-2025

Figure 04: Global Market Share Analysis (%) By Application, 2022 & 2025

Figure 05: Global Market Y-o-Y Growth (%) By Application, 2022-2025

Figure 06: Global Market Attractiveness Analysis, By Application

Figure 07: Global Market Analysis by Route Of Administration –2022 & 2025

Figure 08: Global Market Y-o-Y Growth Projections by Route Of Administration, 2022-2025

Figure 09: Global Market Attractiveness Analysis, By Route Of Administration

Figure 10: Global Market Share Analysis (%) By Marketing, 2022 & 2025

Figure 11: Global Market Y-o-Y Growth (%) By Marketing, 2022-2025

Figure 12: Global Market Attractiveness Analysis, By Marketing 

Figure 13: Global Market Share Analysis (%) By Region, 2022 & 2025

Figure 14: Global Market Y-o-Y Growth (%) By Region, 2022-2025

Figure 15: Global Market Attractiveness Analysis, By Region

Figure 16: North America Market Size (US$ Mn), 2014-2021

Figure 17: North America Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 18: North America Market Attractiveness Analysis by Application, 2022-2025

Figure 19: North America Market Attractiveness Analysis by Marketing, 2022-2025

Figure 20: North America Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 21: North America Market Attractiveness Analysis by Country, 2022-2025

Figure 22: Latin America Market Size (US$ Mn), 2014-2021

Figure 23: Latin America Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 24: Latin America Market Attractiveness Analysis by Application, 2022-2025

Figure 25: Latin America Market Attractiveness Analysis by Marketing, 2022-2025

Figure 26: Latin America Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 27: Latin America Market Attractiveness Analysis by Country, 2022-2025

Figure 28: Western Europe Market Size (US$ Mn), 2014-2021

Figure 29: Western Europe Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 30: Western Europe Market Attractiveness Analysis by Application, 2022-2025

Figure 31: Western Europe Market Attractiveness Analysis by Marketing, 2022-2025

Figure 32: Western Europe Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 33: Western Europe Market Attractiveness Analysis by Country, 2022-2025

Figure 34: Eastern Europe Market Size (US$ Mn), 2014-2021

Figure 35: Eastern Europe Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 36: Eastern Europe Market Attractiveness Analysis by Application, 2022-2025

Figure 37: Eastern Europe Market Attractiveness Analysis by Marketing, 2022-2025

Figure 38: Eastern Europe Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 39: Eastern Europe Market Attractiveness Analysis by Country, 2022-2025

Figure 40: APEJ Market Size (US$ Mn), 2014-2021

Figure 41: APEJ Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 42: APEJ Market Attractiveness Analysis by Application, 2022-2025

Figure 43: APEJ Market Attractiveness Analysis by Marketing, 2022-2025

Figure 44: APEJ Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 45: APEJ Market Attractiveness Analysis by Country, 2022-2025

Figure 46: MEA Market Size (US$ Mn), 2014-2021

Figure 47: MEA Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 48: MEA Market Attractiveness Analysis by Application, 2022-2025

Figure 49: MEA Market Attractiveness Analysis by Marketing, 2022-2025

Figure 50: MEA Market Attractiveness Analysis by Route of Administration, 2022-2025

Figure 51: MEA Market Attractiveness Analysis by Country, 2022-2025

Figure 52: Japan Market Size (US$ Mn), 2014-2021

Figure 53: Japan Market Size (US$) & Y-o-Y Growth (%), 2022-2025

Figure 54: Japan Market Attractiveness Analysis by Application, 2022-2025

Figure 55: Japan Market Attractiveness Analysis by Marketing, 2022-2025

Figure 56: Japan Market Attractiveness Analysis by Route of Administration, 2022-2025

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Autoimmune Disease Therapeutics Market

Published : February 2016

Healthcare

Hepatitis - B Therapeutics Market

Published : February 2016

Healthcare

Lung Cancer Therapeutics Market

Published : February 2022

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Peptide Therapeutics Market